Coronin 1 Loss in Tumor Cells of Glioblastoma Patients Leads to Enhanced Tumor Aggressiveness
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Loss of Coronin 1 protein in glioblastoma cells correlates with increased aggressiveness. Restoring Coronin 1 expression reduces invasion and epithelial-to-mesenchymal transition, suggesting it as a therapeutic target for brain tumors.
Area Of Science
- Neuro-oncology
- Molecular Biology
- Cell Biology
Background
- Glioblastoma (GBM) is an aggressive brain tumor with poor outcomes.
- The tumor microenvironment (TME) influences GBM progression and treatment resistance.
- Glioblastoma cells reduce cAMP levels for survival; inhibiting phosphodiesterases (PDEs) induces apoptosis.
Purpose Of The Study
- To investigate the role of Coronin 1 in glioblastoma.
- To understand why Coronin 1 is lost in glioblastoma tumor cells.
- To explore Coronin 1's potential as a therapeutic target.
Main Methods
- Immunohistochemistry and immunoblotting to detect Coronin 1 expression.
- Overexpression of Coronin 1 in U87 and LN229 glioblastoma cell lines.
- Analysis of downstream targets including Akt, calpain 2, PDE4, and epithelial-to-mesenchymal transition (EMT) markers.
Main Results
- Coronin 1 is expressed in normal brain but lost in most glioblastoma cells, except immune cells and a subset of tumor cells.
- Overexpression of Coronin 1 in glioblastoma cells reduced Akt, calpain 2, PDE4 expression, and EMT phenotype.
- Coronin 1-expressing cells exhibited decreased invasion capacity and extracellular matrix degradation.
Conclusions
- Loss of Coronin 1 expression in glioblastoma may promote tumor aggressiveness by regulating invasion and EMT.
- Coronin 1 downregulation might facilitate the transition to a more invasive glioblastoma phenotype.
- Targeting Coronin 1 could offer novel therapeutic strategies against glioblastoma aggressiveness.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...